GSK-067
GSK-067 (GSK2593067A) is an inhibitor of necroptosis. GSK-067 inhibits PERK-catalyzed phosphorylation of eIF2α. GSK-067 can be used for research on pancreatic cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1337531-05-1
- 分子式: C26H21N5OS
- 分子量:451.55
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- プロトコル
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
製品説明
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| L929 | IC50 |
3 nM
Compound: GSK2593067A; 19
|
Anti-necroptic activity in mouse L929 cells incubated for 3 hrs in presence of TNF alpha/zVAD by celltiter-glo assay
Anti-necroptic activity in mouse L929 cells incubated for 3 hrs in presence of TNF alpha/zVAD by celltiter-glo assay
|
[PMID: 36346971] |
| MOVAS-1 | IC50 |
1 nM
Compound: GSK2593067A; 19
|
Anti-necroptic activity in mouse MOVAS cells incubated for 6 hrs in presence of TNF alpha/zVAD by celltiter-glo assay
Anti-necroptic activity in mouse MOVAS cells incubated for 6 hrs in presence of TNF alpha/zVAD by celltiter-glo assay
|
[PMID: 36346971] |
体外実験
GSK-067 (1-10 μM) is a potent, low-cytotoxicity necroptosis inhibitor in MOVAS and L929 cells[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 1337531-05-1
-
分子量 451.55
-
分子式 C26H21N5OS
-
SMILES
O=C(N1C2=CC=C(C=C2CC1)C3=CSC=4C(=CN=C(N)C43)C=5C=NNC5)CC=6C=CC=CC6
-
別名
GSK2593067A
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Liu B, et al. WO2023034236A1. PCT/US2022/041936. Published 2023 Mar 9.
[2]. Axten JM, et al. Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). Journal of medicinal chemistry. 2012 Aug 23;55(16):7193-207. [Content Brief]
[3]. Zhou T, et al. Identification of a novel class of RIP1/RIP3 dual inhibitors that impede cell death and inflammation in mouse abdominal aortic aneurysm models. Cell death & disease. 2019 Mar 06;10(3):226. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
GSK-067 関連分類
HY-142051 関連分類
Powered by Bioz